miR-15b/16-2 簇在 T 细胞急性淋巴细胞白血病中发挥抑癌作用
该研究通过微阵列分析评估人 T 细胞发育过程中的 miRNA 表达谱,发现 miR-16-2 呈动态表达且 miR-15b 协同调控。功能研究显示 miR-15b/16-2 簇负调控早期胸腺细胞增殖,在 T-ALL 细胞中过表达可损害体外白血病生长及患者来源异种移植模型中的肿瘤进展。机制上,该簇抑制 BCL-2 和 cyclin D3 表达,促进凋亡并导致细胞周期异常。
要点
- miR-15b/16-2 簇负调控早期胸腺细胞增殖,在 T-ALL 中发挥抑癌功能。
- 过表达 miR-15b/16-2 可损害 T-ALL 细胞体外生长及异种移植瘤进展。
- 机制涉及抑制 BCL-2 和 cyclin D3,促进凋亡并致 G0 期积聚及 G2/M 转换缺陷。
核心结论
- miR-15b/16-2 簇在 T-ALL 中具有新型抑癌功能,并可能是潜在治疗靶点。
研究设计与样本
- 使用微阵列分析全面评估人 T 细胞发育过程中的 miRNA 表达谱。
- 在 T-ALL 细胞中进行过表达功能研究,并采用患者来源异种移植实验评估肿瘤进展。
主要发现
- miR-16-2 在早期前 T 细胞增殖阶段至 TCRαβ 表达前的静止未成熟胸腺细胞阶段上调,随后下调。
- miR-15b 表达呈协同调控,与两者聚集的基因组位置一致。
- miR-15b/16-2 簇负调控早期胸腺细胞增殖。
- 过表达 miR-15b/16-2 损害 T-ALL 细胞体外白血病生长及患者来源异种移植中的肿瘤进展。
- miR-15b/16-2 抑制 BCL-2 和 cyclin D3 表达,促进凋亡并导致 G0 期细胞积聚及 G2/M 转换缺陷。
临床怎么用
- miR-15b/16-2 簇可作为 T-ALL 潜在治疗靶点,值得进一步转化研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy arising from the neoplastic transformation of immature T cells during their development in the thymus. Deciphering the developmental programs whose dysregulation drives T-ALL pathogenesis is critical for the development of novel targeted therapies, which remain an urgent unmet need for the treatment of this disease. MicroRNAs (miRNAs) have emerged as key posttranscriptional regulators of numerous physiological processes, including cancer. However, the specific role of miRNAs in human T-cell development and T-ALL pathogenesis remains largely unexplored. In this study, we comprehensively evaluated miRNA expression profiles across human T-cell development using microarray analysis and identified a dynamic expression pattern of miR-16-2, which is upregulated during early pre-T-cell proliferative stages up to the resting stage of immature thymocytes immediately preceding T-cell receptor αβ expression and is subsequently downregulated. We also confirmed the coordinated regulation of miR-15b expression, consistent with the reported clustered genomic location of both miRNAs. Notably, functional studies identified the miR-15b/16-2 cluster as a negative regulator of early thymocyte proliferation and demonstrated that overexpression of miR-15b/16-2 in T-ALL cells impaired leukemic growth in vitro and tumor progression in patient-derived xenotransplantation assays. Mechanistically, miR-15b/16-2 represses the expression of the genes encoding BCL-2 and cyclin D3, thereby promoting apoptosis and cell cycle dysregulation in T-ALL cells, characterized by an accumulation of G0-phase cells and a defective transition to the G2/M phase. Overall, these findings support a novel tumor-suppressive function for miR-15b/16-2 in T-ALL and highlight its potential as a promising therapeutic target.
引用
- Toribio ML, García-León MJ, García-Peydró M, et al. A tumor suppressor role of the miR-15b/16-2 cluster in T-cell acute lymphoblastic leukemia. Blood. 2026. PMID: 41949997. doi:10.1182/blood.2025030670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。